Estimates Revisions Bicycle Therapeutics plc
Stocks
BCYC
US0887861088
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 06/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 3.790 USD | -5.49% |
|
+2.16% | -46.47% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- BCYC Stock
- Consensus Bicycle Therapeutics plc
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
